Claire Feeney

2.5k total citations · 2 hit papers
48 papers, 1.7k citations indexed

About

Claire Feeney is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Claire Feeney has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Dermatology, 19 papers in Immunology and Allergy and 13 papers in Physiology. Recurrent topics in Claire Feeney's work include Dermatology and Skin Diseases (29 papers), Allergic Rhinitis and Sensitization (17 papers) and Asthma and respiratory diseases (12 papers). Claire Feeney is often cited by papers focused on Dermatology and Skin Diseases (29 papers), Allergic Rhinitis and Sensitization (17 papers) and Asthma and respiratory diseases (12 papers). Claire Feeney collaborates with scholars based in United Kingdom, United States and Denmark. Claire Feeney's co-authors include Hernán Valdez, Ricardo Rojo, Eric L. Simpson, Pinaki Biswas, Jacob P. Thyssen, Marco DiBonaventura, Carsten Flohr, Jonathan I. Silverberg, Anthony P. Goldstone and Gary Chan and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Claire Feeney

43 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

2020 313 citations Eric L. Simpson, Michael J. Cork et al. profile →
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

2020 289 citations Jonathan I. Silverberg, Eric L. Simpson et al. profile →

Peers

Countries citing papers authored by Claire Feeney

Since Specialization

Citations

This map shows the geographic impact of Claire Feeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Feeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Feeney more than expected).

Fields of papers citing papers by Claire Feeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Feeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Feeney. The network helps show where Claire Feeney may publish in the future.

Co-authorship network of co-authors of Claire Feeney

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Feeney. A scholar is included among the top collaborators of Claire Feeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Feeney. Claire Feeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	52741 Efficacy of Abrocitinib Versus Dupilumab on Dermatitis in the Head-and-Neck Region of Patients With Moderate-To-Severe Atopic Dermatitis: A Post Hoc Analysis of the Phase 3 JADE DARE Study 2024 ·Journal of the American Academy of Dermatology ·April W. Armstrong, Melinda Gooderham, Kilian Eyerich, Kristian Reich, Andrew Blauvelt, Hwanhee Hong, Roger Edwards, (unknown), (unknown), (unknown), Claire Feeney	0
2	Extraocular muscle Diffusion Weighted Imaging as a quantitative metric of posterior orbital involvement in thyroid associated orbitopathy 2024 ·Insights into Imaging ·(unknown), Claire Feeney, Vickie Lee, Parizad Avari, Amina Ali, Gitta Madani, Ravi Kumar Lingam, (unknown)	5
3	Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMEN 2024 ·Journal of the European Academy of Dermatology and Venereology ·Jacob P. Thyssen, Jonathan I. Silverberg, Juan Ruano, Andrew Blauvelt, (unknown), Eric L. Simpson, Stephan Weidinger, Hernán Valdez, Ketti K. Terry, Pinaki Biswas, Eray Metin Güler, Claire Feeney	0
4	Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis 2023 ·SHILAP Revista de lepidopterología ·D. Staumont‐Sallé, S. Barbarot, Jean‐David Bouaziz, (unknown), Claire Clibborn, A. Du‐Thanh, Claire Feeney, (unknown), L. Misery, Audrey Nosbaum, Julien Sénéschal, A. Soria, Fan Zhang	0
5	Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2 2023 ·American Journal of Clinical Dermatology ·Gil Yosipovitch, Melinda Gooderham, Sonja Ständer, Luz Fonacier, Jacek C. Szepietowski, Mette Deleuran, Giampiero Girolomoni, John Su, Andrew G. Bushmakin, Joseph C. Cappelleri, Claire Feeney, Gary Chan, Andrew Thorpe, Hernán Valdez, Pinaki Biswas, Ricardo Rojo, Marco DiBonaventura, Daniela E. Myers	7
6	44042 Abrocitinib Long-Term Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study 2023 ·Journal of the American Academy of Dermatology ·Kristian Reich, Jonathan I. Silverberg, Marjolein de Bruin‐Weller, Mette Deleuran, Lisa A. Beck, Kim Papp, (unknown), Fan Zhang, Claire Feeney, Herwig Koppensteiner	1
7	Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial 2023 ·American Journal of Clinical Dermatology ·Eric L. Simpson, Jonathan I. Silverberg, Jacob P. Thyssen, M. Viguier, Diamant Thaçi, Marjolein de Bruin‐Weller, Stephan Weidinger, (unknown), Marco DiBonaventura, Pinaki Biswas, Claire Feeney, (unknown), Michael J. Cork	14
8	Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study 2022 ·Journal of Allergy and Clinical Immunology ·Simon de Lusignan, Helen Alexander, (unknown), John Dennis, Andrew McGovern, Claire Feeney, Carsten Flohr	40
9	Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes 2021 ·American Journal of Clinical Dermatology ·Jonathan I. Silverberg, Jacob P. Thyssen, Eric L. Simpson, Gil Yosipovitch, Sonja Ständer, Hernán Valdez, Ricardo Rojo, Pinaki Biswas, Daniela E. Myers, Claire Feeney, Marco DiBonaventura	32
10	A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services 2021 ·Frontiers in Endocrinology ·(unknown), Claire Feeney, Vickie Lee, Sonali Nagendran, Rajni Jain, (unknown), (unknown), Vassiliki Bravis, Karim Meeran	2
11	Association of Other Autoimmune Diseases With Thyroid Eye Disease 2021 ·Frontiers in Endocrinology ·(unknown), Parizad Avari, (unknown), (unknown), Rajni Jain, (unknown), Claire Feeney, Vassiliki Bravis, Karim Meeran, Vickie Lee	7
12	Non-EPI-DWI for Detection, Disease Monitoring, and Clinical Decision-Making in Thyroid Eye Disease 2020 ·American Journal of Neuroradiology ·Claire Feeney, Ravi Kumar Lingam, Vickie Lee, (unknown), Sonali Nagendran	32
13	Epidemiology and management of atopic dermatitis in England: an observational cohort study protocol 2020 ·BMJ Open ·Simon de Lusignan, Helen Alexander, (unknown), John Dennis, Andrew McGovern, Claire Feeney, Carsten Flohr	5
14	089 Atopic Dermatitis Is Associated With an Increased Risk of Autoimmune Diseases: A Population-Based Cohort Study Using UK Primary Care Data 2019 ·Journal of Investigative Dermatology ·Helen Alexander, Simon de Lusignan, (unknown), Claire Feeney, Carsten Flohr	1
15	Addisonian crisis: assessment and management 2018 ·British Journal of Hospital Medicine ·Claire Feeney, Kevin G. Buell, Parizad Avari, Adam Buckley, Karim Meeran, Aled Rees	2
16	Hypophosphatasia and the importance of the general dental practitioner – a case series and discussion of upcoming treatments 2018 ·BDJ ·Claire Feeney, (unknown), (unknown), Siobhan Barry	21
17	Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Claire Feeney, Gregory Scott, Joel Raffel, Stephen Roberts, Christopher Coello, Amy Jolly, Graham E. Searle, Anthony P. Goldstone, David J. Brooks, Richard Nicholas, William Trigg, Roger N. Gunn, David Sharp	56
18	Renal calculi as a presenting feature in a patient with familial hypocalciuric hypercalcaemia (FHH). 2012 ·Endocrine Abstracts ·(unknown), (unknown), Claire Feeney, Daniel Darko, Dimitri Hadjiminas, Jeremy Cox	2
19	Sources of stress and psychological morbidity among undergraduate physiotherapy students 2010 ·Physiotherapy ·Jeremy Walsh, Claire Feeney, Juliette Hussey, Claire Donnellan	79
20	Do medical outpatients want 'out of hours' clinics? 2005 ·BMC Health Services Research ·Claire Feeney, Nicola Roberts, Martyn R Partridge	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact